--- title: "Corvex | 8-K: FY2026 Q1 Revenue: USD 3.653 M" type: "News" locale: "en" url: "https://longbridge.com/en/news/286960526.md" datetime: "2026-05-19T20:09:50.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/286960526.md) - [en](https://longbridge.com/en/news/286960526.md) - [zh-HK](https://longbridge.com/zh-HK/news/286960526.md) --- # Corvex | 8-K: FY2026 Q1 Revenue: USD 3.653 M Revenue: As of FY2026 Q1, the actual value is USD 3.653 M. EPS: As of FY2026 Q1, the actual value is USD -7.81, missing the estimate of USD -3.6. EBIT: As of FY2026 Q1, the actual value is USD -15.19 M. #### Historical Financial Information (in thousands of USD) ##### Three Months Ended March 31, 2026 - Net loss was - $5,005 thousand. - Depreciation and amortization totaled $326 thousand. - Stock-based compensation amounted to $2,178 thousand. - Transaction costs were $719 thousand. - Income tax was - $0 thousand. - Interest expense was $178 thousand. - Adjusted EBITDA was - $1,604 thousand. ##### Year Ended December 31, 2025 - Net loss was - $18,322 thousand. - Depreciation and amortization totaled $149 thousand. - Stock-based compensation amounted to $2,913 thousand. - Transaction costs were $1,093 thousand. - Income tax was - $0 thousand. - Interest expense was $2,782 thousand. - Adjusted EBITDA was - $11,385 thousand. #### Pro Forma Financial Information (in thousands of USD) Corvex, Inc. completed its acquisition of Corvex Legacy Holdings, Inc. on March 19, 2026. The unaudited pro forma condensed combined financial information reflects the combined results as if the Merger had occurred on January 1, 2025. ##### Three Months Ended March 31, 2026 (Pro Forma Combined) - Revenue: $3,653 thousand. - Costs and Expenses: - Cost of revenue (exclusive of depreciation and amortization): $2,193 thousand. - Depreciation and amortization: $2,269 thousand. - Technology and infrastructure: $2,042 thousand. - Sales and marketing: $845 thousand. - General and administrative: $11,674 thousand. - Total costs and expenses: $19,023 thousand. - Loss from operations: - $15,370 thousand. - Other income (expense), net: - Interest expense (related party): - $178 thousand. - Interest and other income, net: - $385 thousand. - Other income (expense), net (subtotal): - $563 thousand. - Net loss and total comprehensive loss: - $15,933 thousand. - Net loss per share, basic and diluted: - $7.81. - Weighted average shares used in computing net loss per share, basic and diluted: 2,039,726. - Net loss: - $15,933 thousand. - Depreciation and amortization: $2,269 thousand. - Stock-based compensation: $10,344 thousand. - Transaction costs: $1,824 thousand. - Income tax: - $0 thousand. - Interest expense: $563 thousand. - Adjusted EBITDA: - $933 thousand. ##### Year Ended December 31, 2025 (Pro Forma Combined) - Revenue: $7,535 thousand. - Costs and Expenses: - Cost of revenue (exclusive of depreciation and amortization): $7,868 thousand. - Depreciation and amortization: $5,602 thousand. - Technology and infrastructure: $11,366 thousand. - Research and development: $0 thousand. - Sales and marketing: $3,809 thousand. - General and administrative: $44,400 thousand. - Sales, general and administrative: $0 thousand. - Total costs and expenses: $73,045 thousand. - Loss from operations: - $65,510 thousand. - Other income (expense), net: - Interest expense (related party): - $2,965 thousand. - Loss (gain) change in warrant liability fair value: $0 thousand. - Loss (Gain) in fair value of SAFE liability: $0 thousand. - Interest and other income, net: $136 thousand. - Other income (expense), net (subtotal): - $2,829 thousand. - Income tax benefits (expense): - $60 thousand. - Net loss and total comprehensive loss: - $68,399 thousand. - Net loss per share, basic and diluted: - $33.53. - Weighted average shares used in computing net loss per share, basic and diluted: 2,039,726. - Net loss: - $68,399 thousand. - Depreciation and amortization: $5,602 thousand. - Stock-based compensation: $42,031 thousand. - Transaction costs: $4,209 thousand. - Income tax: $60 thousand. - Interest expense: $2,829 thousand. - Adjusted EBITDA: - $13,668 thousand. #### Unique Metrics Corvex, Inc. utilizes Adjusted EBITDA, a non-GAAP financial measure, defined as net loss adjusted for depreciation and amortization, stock-based compensation, transaction costs, income tax expense, and net interest and other expense (income). Management considers Adjusted EBITDA useful for investors by excluding items not indicative of core operating performance, though it has limitations as an analytical tool. Regarding the acquisition of Corvex Legacy Holdings, Inc., the estimated consideration transferred (Purchase Price) was $581,911 thousand. Goodwill of $518,263 thousand was recorded, and identifiable intangible assets included customer relationships of $5,190 thousand and trade names of $10,210 thousand. #### Outlook / Guidance The unaudited pro forma condensed combined financial information is solely for informational purposes and does not indicate future financial conditions or results. It also does not incorporate management adjustments for potential cost savings or operating efficiencies resulting from the Merger. The reference explicitly states that no outlook or guidance is provided within the text. ### Related Stocks - [MOVE.US](https://longbridge.com/en/quote/MOVE.US.md) ## Related News & Research - [Corvex, Inc. 1Q 2026: Revenue $510K, EPS ($3.13) — 10-Q Summary](https://longbridge.com/en/news/286961017.md) - [Capstone Companies, Inc. announces Execution of Binding Letter of Intent with eBliss Global, Inc. | CAPC Stock News](https://longbridge.com/en/news/286782166.md) - [Fermi Inc. Outlines Fermi 2.0 Strategic Evolution and Reports First Quarter 2026 Financial Results | FRMI Stock News](https://longbridge.com/en/news/286403515.md) - [Karbon-X and Evertrak Sign Letter of Intent to Advance Infrastructure-Linked Plastic Waste Reduction Credit Initiative | KARX Stock News](https://longbridge.com/en/news/286950981.md) - [Ethic Inc. Sells 6,534 Shares of Astera Labs, Inc. $ALAB](https://longbridge.com/en/news/286526653.md)